Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function.

van Bommel EJM, Lytvyn Y, Perkins BA, Soleymanlou N, Fagan NM, Koitka-Weber A, Joles JA, Cherney DZI, van Raalte DH.

Kidney Int. 2020 Apr;97(4):631-635. doi: 10.1016/j.kint.2019.12.021. No abstract available.

PMID:
32200854
2.

Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease.

van de Wouw J, Sorop O, van Drie RWA, van Duin RWB, Nguyen ITN, Joles JA, Verhaar MC, Merkus D, Duncker DJ.

Basic Res Cardiol. 2020 Feb 25;115(2):21. doi: 10.1007/s00395-020-0778-2.

3.

Sodium Thiosulfate in the Pregnant Dahl Salt-Sensitive Rat, a Model of Preeclampsia.

Terstappen F, Clarke SM, Joles JA, Ross CA, Garrett MR, Minnion M, Feelisch M, Goor HV, Sasser JM, Lely AT.

Biomolecules. 2020 Feb 14;10(2). pii: E302. doi: 10.3390/biom10020302.

4.

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

Kruithof PD, Lunev S, Aguilar Lozano SP, de Assis Batista F, Al-Dahmani ZM, Joles JA, Dolga AM, Groves MR, van Goor H.

Biochim Biophys Acta Mol Basis Dis. 2020 Feb 19;1866(6):165716. doi: 10.1016/j.bbadis.2020.165716. [Epub ahead of print] Review.

PMID:
32061776
5.

Longitudinal follow-up of kidney function in patients with a history of preeclampsia: From 11 to 18 years postpartum.

Roessingh T, Zoet GA, Franx A, Maas AHEM, Navis G, Joles JA, Lely TA, Paauw ND.

Pregnancy Hypertens. 2020 Jan;19:187-189. doi: 10.1016/j.preghy.2020.01.007. Epub 2020 Jan 14.

PMID:
32059138
6.

Conflicting Effects of Fetal Growth Restriction on Blood Pressure Between Human and Rat Offspring: A Meta-Analysis.

Kooiman J, Terstappen F, van Wagensveld L, Franx A, Wever KE, Roseboom TJ, Joles JA, Gremmels H, Lely AT.

Hypertension. 2020 Mar;75(3):806-818. doi: 10.1161/HYPERTENSIONAHA.119.14111. Epub 2020 Jan 27.

PMID:
31983304
7.

Special issue on magnetic resonance imaging biomarkers of renal disease.

Hockings P, Laustsen C, Joles JA, Mark PB, Sourbron S.

MAGMA. 2020 Feb;33(1):1-2. doi: 10.1007/s10334-019-00822-7. No abstract available.

PMID:
31897904
8.

Decreased native renal T1 up to one week after gadobutrol administration in healthy volunteers.

de Boer A, Harteveld AA, Pieters TT, Blankestijn PJ, Bos C, Froeling M, Joles JA, Verhaar MC, Leiner T, Hoogduin H.

J Magn Reson Imaging. 2019 Dec 4. doi: 10.1002/jmri.27014. [Epub ahead of print]

PMID:
31799793
9.

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.

van Bommel EJM, Muskiet MHA, van Baar MJB, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser AHJ, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer MHH, Nieuwdorp M, Joles JA, van Raalte DH.

Kidney Int. 2020 Jan;97(1):202-212. doi: 10.1016/j.kint.2019.09.013. Epub 2019 Oct 10.

PMID:
31791665
10.

Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury.

Uijl E, 't Hart DC, Roksnoer LCW, Groningen MCC, van Veghel R, Garrelds IM, de Vries R, van der Vlag J, Zietse R, Nijenhuis T, Joles JA, Hoorn EJ, Danser AHJ.

J Hypertens. 2020 Apr;38(4):755-764. doi: 10.1097/HJH.0000000000002326.

PMID:
31790054
11.

Measuring systolic and diastolic blood pressure in rodents.

Joles JA.

Kidney Int. 2019 Dec;96(6):1424-1425. doi: 10.1016/j.kint.2019.09.005. No abstract available.

PMID:
31759491
12.

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.

van Bommel EJM, Ruiter D, Muskiet MHA, van Baar MJB, Kramer MHH, Nieuwdorp M, Joles JA, Bjornstad P, van Raalte DH.

Diabetes Care. 2020 Jan;43(1):228-234. doi: 10.2337/dc19-1651. Epub 2019 Oct 29.

PMID:
31662305
13.

Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantation.

Krebber MM, Papazova DA, Oosterhuis NR, Mokry M, Cramer MJ, Cheng C, Joles JA, Verhaar MC.

J Hypertens. 2020 Mar;38(3):489-503. doi: 10.1097/HJH.0000000000002285.

PMID:
31652182
14.

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets.

van de Wouw J, Broekhuizen M, Sorop O, Joles JA, Verhaar MC, Duncker DJ, Danser AHJ, Merkus D.

Front Physiol. 2019 Sep 4;10:1108. doi: 10.3389/fphys.2019.01108. eCollection 2019. Review.

15.

Renal sinus fat and renal hemodynamics: a cross-sectional analysis.

Spit KA, Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Joles JA, de Boer A, van Raalte DH.

MAGMA. 2020 Feb;33(1):73-80. doi: 10.1007/s10334-019-00773-z. Epub 2019 Aug 31.

16.

Plasma uric acid and renal haemodynamics in type 2 diabetes patients.

Suijk DL, Smits MM, Muskiet MH, Tonneijck L, Kramer MH, Joles JA, van Raalte DH.

Nephrology (Carlton). 2020 Apr;25(4):290-297. doi: 10.1111/nep.13645. Epub 2019 Sep 12.

17.

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

Eisenga MF, Emans ME, van der Putten K, Cramer MJ, Diepenbroek A, Velthuis BK, Doevendans PA, Verhaar MC, Joles JA, Bakker SJL, Nolte IM, Braam B, Gaillard CAJM.

J Am Heart Assoc. 2019 Aug 20;8(16):e011130. doi: 10.1161/JAHA.118.011130. Epub 2019 Aug 17.

18.

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

van Baar MJB, van der Aart AB, Hoogenberg K, Joles JA, Heerspink HJL, van Raalte DH.

Ther Adv Endocrinol Metab. 2019 Jul 24;10:2042018819865398. doi: 10.1177/2042018819865398. eCollection 2019. Review.

19.

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.

Brandt MM, Nguyen ITN, Krebber MM, van de Wouw J, Mokry M, Cramer MJ, Duncker DJ, Verhaar MC, Joles JA, Cheng C.

J Cell Mol Med. 2019 Oct;23(10):6666-6678. doi: 10.1111/jcmm.14542. Epub 2019 Jul 31.

20.

Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearance.

Muskiet MHA, Emanuel AL, Smits MM, Tonneijck L, Meijer RI, Joles JA, Serné EH, van Raalte DH.

Microcirculation. 2019 Oct;26(7):e12580. doi: 10.1111/micc.12580. Epub 2019 Aug 26.

PMID:
31313410

Supplemental Content

Loading ...
Support Center